4.4. Limitations
Findings from our study should be viewed with caution in light of several methodological limitations. First, while our use of remote decentralized controlled trials (RDCT) is seen as a positive attempt to be more inclusive of historically underrepresented groups in clinical trials, it can have some unintended consequences. For example, RDCTs may transfer the trial activity burden onto participants and remote-working research staff; therefore, additional support may be needed [